Global Recombinant Protein Drug Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Recombinant Protein Drug market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Recombinant Protein Drug market are covered in Chapter 9:
Pharmingen
Anhui Anke Biotechnology
Livzon Pharmaceutical
Heng Rui
GenSci
Roche
Amgen
Merck Serono
Shenzhen Neptunus Interlong Bio-Technique
Changchun High & New Technology Industry
Sanofi
Ortho Biotech
Abcam
Eli Lilly
NCPC
Kyowa Hakko Kirin
Novo Nordisk
SL PHARM
In Chapter 5 and Chapter 7.3, based on types, the Recombinant Protein Drug market from 2017 to 2027 is primarily split into:
Recombinant Insulin
Recombinant Human Interferon (rhIFN)
Recombinant Human Erythropoietin (rhEPO)
Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF)
Recombinant Human Growth Hormone (rhGH)
Recombinant Human Follicle-stimulating Hormone (rhFSH)
Others
In Chapter 6 and Chapter 7.4, based on applications, the Recombinant Protein Drug market from 2017 to 2027 covers:
Hospital use
Clinic use
Household
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Recombinant Protein Drug market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Recombinant Protein Drug Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Recombinant Protein Drug market are covered in Chapter 9:
Pharmingen
Anhui Anke Biotechnology
Livzon Pharmaceutical
Heng Rui
GenSci
Roche
Amgen
Merck Serono
Shenzhen Neptunus Interlong Bio-Technique
Changchun High & New Technology Industry
Sanofi
Ortho Biotech
Abcam
Eli Lilly
NCPC
Kyowa Hakko Kirin
Novo Nordisk
SL PHARM
In Chapter 5 and Chapter 7.3, based on types, the Recombinant Protein Drug market from 2017 to 2027 is primarily split into:
Recombinant Insulin
Recombinant Human Interferon (rhIFN)
Recombinant Human Erythropoietin (rhEPO)
Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF)
Recombinant Human Growth Hormone (rhGH)
Recombinant Human Follicle-stimulating Hormone (rhFSH)
Others
In Chapter 6 and Chapter 7.4, based on applications, the Recombinant Protein Drug market from 2017 to 2027 covers:
Hospital use
Clinic use
Household
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Recombinant Protein Drug market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Recombinant Protein Drug Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 RECOMBINANT PROTEIN DRUG MARKET OVERVIEW
1.1 Product Overview and Scope of Recombinant Protein Drug Market
1.2 Recombinant Protein Drug Market Segment by Type
1.2.1 Global Recombinant Protein Drug Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Recombinant Protein Drug Market Segment by Application
1.3.1 Recombinant Protein Drug Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Recombinant Protein Drug Market, Region Wise (2017-2027)
1.4.1 Global Recombinant Protein Drug Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Recombinant Protein Drug Market Status and Prospect (2017-2027)
1.4.3 Europe Recombinant Protein Drug Market Status and Prospect (2017-2027)
1.4.4 China Recombinant Protein Drug Market Status and Prospect (2017-2027)
1.4.5 Japan Recombinant Protein Drug Market Status and Prospect (2017-2027)
1.4.6 India Recombinant Protein Drug Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Recombinant Protein Drug Market Status and Prospect (2017-2027)
1.4.8 Latin America Recombinant Protein Drug Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Recombinant Protein Drug Market Status and Prospect (2017-2027)
1.5 Global Market Size of Recombinant Protein Drug (2017-2027)
1.5.1 Global Recombinant Protein Drug Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Recombinant Protein Drug Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Recombinant Protein Drug Market
2 INDUSTRY OUTLOOK
2.1 Recombinant Protein Drug Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Recombinant Protein Drug Market Drivers Analysis
2.4 Recombinant Protein Drug Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Recombinant Protein Drug Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Recombinant Protein Drug Industry Development
3 GLOBAL RECOMBINANT PROTEIN DRUG MARKET LANDSCAPE BY PLAYER
3.1 Global Recombinant Protein Drug Sales Volume and Share by Player (2017-2022)
3.2 Global Recombinant Protein Drug Revenue and Market Share by Player (2017-2022)
3.3 Global Recombinant Protein Drug Average Price by Player (2017-2022)
3.4 Global Recombinant Protein Drug Gross Margin by Player (2017-2022)
3.5 Recombinant Protein Drug Market Competitive Situation and Trends
3.5.1 Recombinant Protein Drug Market Concentration Rate
3.5.2 Recombinant Protein Drug Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL RECOMBINANT PROTEIN DRUG SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Recombinant Protein Drug Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Recombinant Protein Drug Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Recombinant Protein Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Recombinant Protein Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Recombinant Protein Drug Market Under COVID-19
4.5 Europe Recombinant Protein Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Recombinant Protein Drug Market Under COVID-19
4.6 China Recombinant Protein Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Recombinant Protein Drug Market Under COVID-19
4.7 Japan Recombinant Protein Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Recombinant Protein Drug Market Under COVID-19
4.8 India Recombinant Protein Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Recombinant Protein Drug Market Under COVID-19
4.9 Southeast Asia Recombinant Protein Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Recombinant Protein Drug Market Under COVID-19
4.10 Latin America Recombinant Protein Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Recombinant Protein Drug Market Under COVID-19
4.11 Middle East and Africa Recombinant Protein Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Recombinant Protein Drug Market Under COVID-19
5 GLOBAL RECOMBINANT PROTEIN DRUG SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Recombinant Protein Drug Sales Volume and Market Share by Type (2017-2022)
5.2 Global Recombinant Protein Drug Revenue and Market Share by Type (2017-2022)
5.3 Global Recombinant Protein Drug Price by Type (2017-2022)
5.4 Global Recombinant Protein Drug Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Recombinant Protein Drug Sales Volume, Revenue and Growth Rate of Recombinant Insulin (2017-2022)
5.4.2 Global Recombinant Protein Drug Sales Volume, Revenue and Growth Rate of Recombinant Human Interferon (rhIFN) (2017-2022)
5.4.3 Global Recombinant Protein Drug Sales Volume, Revenue and Growth Rate of Recombinant Human Erythropoietin (rhEPO) (2017-2022)
5.4.4 Global Recombinant Protein Drug Sales Volume, Revenue and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) (2017-2022)
5.4.5 Global Recombinant Protein Drug Sales Volume, Revenue and Growth Rate of Recombinant Human Growth Hormone (rhGH) (2017-2022)
5.4.6 Global Recombinant Protein Drug Sales Volume, Revenue and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rhFSH) (2017-2022)
5.4.7 Global Recombinant Protein Drug Sales Volume, Revenue and Growth Rate of Others (2017-2022)
6 GLOBAL RECOMBINANT PROTEIN DRUG MARKET ANALYSIS BY APPLICATION
6.1 Global Recombinant Protein Drug Consumption and Market Share by Application (2017-2022)
6.2 Global Recombinant Protein Drug Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Recombinant Protein Drug Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Recombinant Protein Drug Consumption and Growth Rate of Hospital use (2017-2022)
6.3.2 Global Recombinant Protein Drug Consumption and Growth Rate of Clinic use (2017-2022)
6.3.3 Global Recombinant Protein Drug Consumption and Growth Rate of Household (2017-2022)
7 GLOBAL RECOMBINANT PROTEIN DRUG MARKET FORECAST (2022-2027)
7.1 Global Recombinant Protein Drug Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Recombinant Protein Drug Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Recombinant Protein Drug Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Recombinant Protein Drug Price and Trend Forecast (2022-2027)
7.2 Global Recombinant Protein Drug Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Recombinant Protein Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Recombinant Protein Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Recombinant Protein Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Recombinant Protein Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Recombinant Protein Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Recombinant Protein Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Recombinant Protein Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Recombinant Protein Drug Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Recombinant Protein Drug Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Insulin (2022-2027)
7.3.2 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Human Interferon (rhIFN) (2022-2027)
7.3.3 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Human Erythropoietin (rhEPO) (2022-2027)
7.3.4 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) (2022-2027)
7.3.5 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Human Growth Hormone (rhGH) (2022-2027)
7.3.6 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rhFSH) (2022-2027)
7.3.7 Global Recombinant Protein Drug Revenue and Growth Rate of Others (2022-2027)
7.4 Global Recombinant Protein Drug Consumption Forecast by Application (2022-2027)
7.4.1 Global Recombinant Protein Drug Consumption Value and Growth Rate of Hospital use(2022-2027)
7.4.2 Global Recombinant Protein Drug Consumption Value and Growth Rate of Clinic use(2022-2027)
7.4.3 Global Recombinant Protein Drug Consumption Value and Growth Rate of Household(2022-2027)
7.5 Recombinant Protein Drug Market Forecast Under COVID-19
8 RECOMBINANT PROTEIN DRUG MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Recombinant Protein Drug Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Recombinant Protein Drug Analysis
8.6 Major Downstream Buyers of Recombinant Protein Drug Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Recombinant Protein Drug Industry
9 PLAYERS PROFILES
9.1 Pharmingen
9.1.1 Pharmingen Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.1.3 Pharmingen Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Anhui Anke Biotechnology
9.2.1 Anhui Anke Biotechnology Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.2.3 Anhui Anke Biotechnology Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Livzon Pharmaceutical
9.3.1 Livzon Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.3.3 Livzon Pharmaceutical Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Heng Rui
9.4.1 Heng Rui Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.4.3 Heng Rui Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 GenSci
9.5.1 GenSci Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.5.3 GenSci Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Roche
9.6.1 Roche Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.6.3 Roche Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Amgen
9.7.1 Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.7.3 Amgen Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Merck Serono
9.8.1 Merck Serono Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.8.3 Merck Serono Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Shenzhen Neptunus Interlong Bio-Technique
9.9.1 Shenzhen Neptunus Interlong Bio-Technique Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.9.3 Shenzhen Neptunus Interlong Bio-Technique Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Changchun High & New Technology Industry
9.10.1 Changchun High & New Technology Industry Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.10.3 Changchun High & New Technology Industry Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Sanofi
9.11.1 Sanofi Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.11.3 Sanofi Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Ortho Biotech
9.12.1 Ortho Biotech Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.12.3 Ortho Biotech Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Abcam
9.13.1 Abcam Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.13.3 Abcam Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Eli Lilly
9.14.1 Eli Lilly Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.14.3 Eli Lilly Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 NCPC
9.15.1 NCPC Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.15.3 NCPC Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Kyowa Hakko Kirin
9.16.1 Kyowa Hakko Kirin Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.16.3 Kyowa Hakko Kirin Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Novo Nordisk
9.17.1 Novo Nordisk Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.17.3 Novo Nordisk Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
9.18 SL PHARM
9.18.1 SL PHARM Basic Information, Manufacturing Base, Sales Region and Competitors
9.18.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.18.3 SL PHARM Market Performance (2017-2022)
9.18.4 Recent Development
9.18.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Recombinant Protein Drug Market
1.2 Recombinant Protein Drug Market Segment by Type
1.2.1 Global Recombinant Protein Drug Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Recombinant Protein Drug Market Segment by Application
1.3.1 Recombinant Protein Drug Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Recombinant Protein Drug Market, Region Wise (2017-2027)
1.4.1 Global Recombinant Protein Drug Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Recombinant Protein Drug Market Status and Prospect (2017-2027)
1.4.3 Europe Recombinant Protein Drug Market Status and Prospect (2017-2027)
1.4.4 China Recombinant Protein Drug Market Status and Prospect (2017-2027)
1.4.5 Japan Recombinant Protein Drug Market Status and Prospect (2017-2027)
1.4.6 India Recombinant Protein Drug Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Recombinant Protein Drug Market Status and Prospect (2017-2027)
1.4.8 Latin America Recombinant Protein Drug Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Recombinant Protein Drug Market Status and Prospect (2017-2027)
1.5 Global Market Size of Recombinant Protein Drug (2017-2027)
1.5.1 Global Recombinant Protein Drug Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Recombinant Protein Drug Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Recombinant Protein Drug Market
2 INDUSTRY OUTLOOK
2.1 Recombinant Protein Drug Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Recombinant Protein Drug Market Drivers Analysis
2.4 Recombinant Protein Drug Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Recombinant Protein Drug Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Recombinant Protein Drug Industry Development
3 GLOBAL RECOMBINANT PROTEIN DRUG MARKET LANDSCAPE BY PLAYER
3.1 Global Recombinant Protein Drug Sales Volume and Share by Player (2017-2022)
3.2 Global Recombinant Protein Drug Revenue and Market Share by Player (2017-2022)
3.3 Global Recombinant Protein Drug Average Price by Player (2017-2022)
3.4 Global Recombinant Protein Drug Gross Margin by Player (2017-2022)
3.5 Recombinant Protein Drug Market Competitive Situation and Trends
3.5.1 Recombinant Protein Drug Market Concentration Rate
3.5.2 Recombinant Protein Drug Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL RECOMBINANT PROTEIN DRUG SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Recombinant Protein Drug Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Recombinant Protein Drug Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Recombinant Protein Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Recombinant Protein Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Recombinant Protein Drug Market Under COVID-19
4.5 Europe Recombinant Protein Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Recombinant Protein Drug Market Under COVID-19
4.6 China Recombinant Protein Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Recombinant Protein Drug Market Under COVID-19
4.7 Japan Recombinant Protein Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Recombinant Protein Drug Market Under COVID-19
4.8 India Recombinant Protein Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Recombinant Protein Drug Market Under COVID-19
4.9 Southeast Asia Recombinant Protein Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Recombinant Protein Drug Market Under COVID-19
4.10 Latin America Recombinant Protein Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Recombinant Protein Drug Market Under COVID-19
4.11 Middle East and Africa Recombinant Protein Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Recombinant Protein Drug Market Under COVID-19
5 GLOBAL RECOMBINANT PROTEIN DRUG SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Recombinant Protein Drug Sales Volume and Market Share by Type (2017-2022)
5.2 Global Recombinant Protein Drug Revenue and Market Share by Type (2017-2022)
5.3 Global Recombinant Protein Drug Price by Type (2017-2022)
5.4 Global Recombinant Protein Drug Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Recombinant Protein Drug Sales Volume, Revenue and Growth Rate of Recombinant Insulin (2017-2022)
5.4.2 Global Recombinant Protein Drug Sales Volume, Revenue and Growth Rate of Recombinant Human Interferon (rhIFN) (2017-2022)
5.4.3 Global Recombinant Protein Drug Sales Volume, Revenue and Growth Rate of Recombinant Human Erythropoietin (rhEPO) (2017-2022)
5.4.4 Global Recombinant Protein Drug Sales Volume, Revenue and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) (2017-2022)
5.4.5 Global Recombinant Protein Drug Sales Volume, Revenue and Growth Rate of Recombinant Human Growth Hormone (rhGH) (2017-2022)
5.4.6 Global Recombinant Protein Drug Sales Volume, Revenue and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rhFSH) (2017-2022)
5.4.7 Global Recombinant Protein Drug Sales Volume, Revenue and Growth Rate of Others (2017-2022)
6 GLOBAL RECOMBINANT PROTEIN DRUG MARKET ANALYSIS BY APPLICATION
6.1 Global Recombinant Protein Drug Consumption and Market Share by Application (2017-2022)
6.2 Global Recombinant Protein Drug Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Recombinant Protein Drug Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Recombinant Protein Drug Consumption and Growth Rate of Hospital use (2017-2022)
6.3.2 Global Recombinant Protein Drug Consumption and Growth Rate of Clinic use (2017-2022)
6.3.3 Global Recombinant Protein Drug Consumption and Growth Rate of Household (2017-2022)
7 GLOBAL RECOMBINANT PROTEIN DRUG MARKET FORECAST (2022-2027)
7.1 Global Recombinant Protein Drug Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Recombinant Protein Drug Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Recombinant Protein Drug Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Recombinant Protein Drug Price and Trend Forecast (2022-2027)
7.2 Global Recombinant Protein Drug Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Recombinant Protein Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Recombinant Protein Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Recombinant Protein Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Recombinant Protein Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Recombinant Protein Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Recombinant Protein Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Recombinant Protein Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Recombinant Protein Drug Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Recombinant Protein Drug Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Insulin (2022-2027)
7.3.2 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Human Interferon (rhIFN) (2022-2027)
7.3.3 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Human Erythropoietin (rhEPO) (2022-2027)
7.3.4 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) (2022-2027)
7.3.5 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Human Growth Hormone (rhGH) (2022-2027)
7.3.6 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rhFSH) (2022-2027)
7.3.7 Global Recombinant Protein Drug Revenue and Growth Rate of Others (2022-2027)
7.4 Global Recombinant Protein Drug Consumption Forecast by Application (2022-2027)
7.4.1 Global Recombinant Protein Drug Consumption Value and Growth Rate of Hospital use(2022-2027)
7.4.2 Global Recombinant Protein Drug Consumption Value and Growth Rate of Clinic use(2022-2027)
7.4.3 Global Recombinant Protein Drug Consumption Value and Growth Rate of Household(2022-2027)
7.5 Recombinant Protein Drug Market Forecast Under COVID-19
8 RECOMBINANT PROTEIN DRUG MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Recombinant Protein Drug Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Recombinant Protein Drug Analysis
8.6 Major Downstream Buyers of Recombinant Protein Drug Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Recombinant Protein Drug Industry
9 PLAYERS PROFILES
9.1 Pharmingen
9.1.1 Pharmingen Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.1.3 Pharmingen Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Anhui Anke Biotechnology
9.2.1 Anhui Anke Biotechnology Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.2.3 Anhui Anke Biotechnology Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Livzon Pharmaceutical
9.3.1 Livzon Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.3.3 Livzon Pharmaceutical Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Heng Rui
9.4.1 Heng Rui Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.4.3 Heng Rui Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 GenSci
9.5.1 GenSci Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.5.3 GenSci Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Roche
9.6.1 Roche Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.6.3 Roche Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Amgen
9.7.1 Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.7.3 Amgen Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Merck Serono
9.8.1 Merck Serono Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.8.3 Merck Serono Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Shenzhen Neptunus Interlong Bio-Technique
9.9.1 Shenzhen Neptunus Interlong Bio-Technique Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.9.3 Shenzhen Neptunus Interlong Bio-Technique Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Changchun High & New Technology Industry
9.10.1 Changchun High & New Technology Industry Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.10.3 Changchun High & New Technology Industry Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Sanofi
9.11.1 Sanofi Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.11.3 Sanofi Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Ortho Biotech
9.12.1 Ortho Biotech Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.12.3 Ortho Biotech Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Abcam
9.13.1 Abcam Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.13.3 Abcam Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Eli Lilly
9.14.1 Eli Lilly Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.14.3 Eli Lilly Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 NCPC
9.15.1 NCPC Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.15.3 NCPC Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Kyowa Hakko Kirin
9.16.1 Kyowa Hakko Kirin Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.16.3 Kyowa Hakko Kirin Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Novo Nordisk
9.17.1 Novo Nordisk Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.17.3 Novo Nordisk Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
9.18 SL PHARM
9.18.1 SL PHARM Basic Information, Manufacturing Base, Sales Region and Competitors
9.18.2 Recombinant Protein Drug Product Profiles, Application and Specification
9.18.3 SL PHARM Market Performance (2017-2022)
9.18.4 Recent Development
9.18.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Recombinant Protein Drug Product Picture
Table Global Recombinant Protein Drug Market Sales Volume and CAGR (%) Comparison by Type
Table Recombinant Protein Drug Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Recombinant Protein Drug Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Recombinant Protein Drug Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Recombinant Protein Drug Industry Development
Table Global Recombinant Protein Drug Sales Volume by Player (2017-2022)
Table Global Recombinant Protein Drug Sales Volume Share by Player (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume Share by Player in 2021
Table Recombinant Protein Drug Revenue (Million USD) by Player (2017-2022)
Table Recombinant Protein Drug Revenue Market Share by Player (2017-2022)
Table Recombinant Protein Drug Price by Player (2017-2022)
Table Recombinant Protein Drug Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Recombinant Protein Drug Sales Volume, Region Wise (2017-2022)
Table Global Recombinant Protein Drug Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume Market Share, Region Wise in 2021
Table Global Recombinant Protein Drug Revenue (Million USD), Region Wise (2017-2022)
Table Global Recombinant Protein Drug Revenue Market Share, Region Wise (2017-2022)
Figure Global Recombinant Protein Drug Revenue Market Share, Region Wise (2017-2022)
Figure Global Recombinant Protein Drug Revenue Market Share, Region Wise in 2021
Table Global Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Recombinant Protein Drug Sales Volume by Type (2017-2022)
Table Global Recombinant Protein Drug Sales Volume Market Share by Type (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume Market Share by Type in 2021
Table Global Recombinant Protein Drug Revenue (Million USD) by Type (2017-2022)
Table Global Recombinant Protein Drug Revenue Market Share by Type (2017-2022)
Figure Global Recombinant Protein Drug Revenue Market Share by Type in 2021
Table Recombinant Protein Drug Price by Type (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume and Growth Rate of Recombinant Insulin (2017-2022)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Insulin (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume and Growth Rate of Recombinant Human Interferon (rhIFN) (2017-2022)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Interferon (rhIFN) (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume and Growth Rate of Recombinant Human Erythropoietin (rhEPO) (2017-2022)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Erythropoietin (rhEPO) (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) (2017-2022)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume and Growth Rate of Recombinant Human Growth Hormone (rhGH) (2017-2022)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Growth Hormone (rhGH) (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rhFSH) (2017-2022)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rhFSH) (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Recombinant Protein Drug Consumption by Application (2017-2022)
Table Global Recombinant Protein Drug Consumption Market Share by Application (2017-2022)
Table Global Recombinant Protein Drug Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Recombinant Protein Drug Consumption Revenue Market Share by Application (2017-2022)
Table Global Recombinant Protein Drug Consumption and Growth Rate of Hospital use (2017-2022)
Table Global Recombinant Protein Drug Consumption and Growth Rate of Clinic use (2017-2022)
Table Global Recombinant Protein Drug Consumption and Growth Rate of Household (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Recombinant Protein Drug Price and Trend Forecast (2022-2027)
Figure USA Recombinant Protein Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Recombinant Protein Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Recombinant Protein Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Recombinant Protein Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Recombinant Protein Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Recombinant Protein Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Recombinant Protein Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Recombinant Protein Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Recombinant Protein Drug Market Sales Volume Forecast, by Type
Table Global Recombinant Protein Drug Sales Volume Market Share Forecast, by Type
Table Global Recombinant Protein Drug Market Revenue (Million USD) Forecast, by Type
Table Global Recombinant Protein Drug Revenue Market Share Forecast, by Type
Table Global Recombinant Protein Drug Price Forecast, by Type
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Insulin (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Insulin (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Interferon (rhIFN) (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Interferon (rhIFN) (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Erythropoietin (rhEPO) (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Erythropoietin (rhEPO) (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Growth Hormone (rhGH) (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Growth Hormone (rhGH) (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rhFSH) (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rhFSH) (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Recombinant Protein Drug Market Consumption Forecast, by Application
Table Global Recombinant Protein Drug Consumption Market Share Forecast, by Application
Table Global Recombinant Protein Drug Market Revenue (Million USD) Forecast, by Application
Table Global Recombinant Protein Drug Revenue Market Share Forecast, by Application
Figure Global Recombinant Protein Drug Consumption Value (Million USD) and Growth Rate of Hospital use (2022-2027)
Figure Global Recombinant Protein Drug Consumption Value (Million USD) and Growth Rate of Clinic use (2022-2027)
Figure Global Recombinant Protein Drug Consumption Value (Million USD) and Growth Rate of Household (2022-2027)
Figure Recombinant Protein Drug Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Pharmingen Profile
Table Pharmingen Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pharmingen Recombinant Protein Drug Sales Volume and Growth Rate
Figure Pharmingen Revenue (Million USD) Market Share 2017-2022
Table Anhui Anke Biotechnology Profile
Table Anhui Anke Biotechnology Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Anhui Anke Biotechnology Recombinant Protein Drug Sales Volume and Growth Rate
Figure Anhui Anke Biotechnology Revenue (Million USD) Market Share 2017-2022
Table Livzon Pharmaceutical Profile
Table Livzon Pharmaceutical Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Livzon Pharmaceutical Recombinant Protein Drug Sales Volume and Growth Rate
Figure Livzon Pharmaceutical Revenue (Million USD) Market Share 2017-2022
Table Heng Rui Profile
Table Heng Rui Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Heng Rui Recombinant Protein Drug Sales Volume and Growth Rate
Figure Heng Rui Revenue (Million USD) Market Share 2017-2022
Table GenSci Profile
Table GenSci Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GenSci Recombinant Protein Drug Sales Volume and Growth Rate
Figure GenSci Revenue (Million USD) Market Share 2017-2022
Table Roche Profile
Table Roche Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Roche Recombinant Protein Drug Sales Volume and Growth Rate
Figure Roche Revenue (Million USD) Market Share 2017-2022
Table Amgen Profile
Table Amgen Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Recombinant Protein Drug Sales Volume and Growth Rate
Figure Amgen Revenue (Million USD) Market Share 2017-2022
Table Merck Serono Profile
Table Merck Serono Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck Serono Recombinant Protein Drug Sales Volume and Growth Rate
Figure Merck Serono Revenue (Million USD) Market Share 2017-2022
Table Shenzhen Neptunus Interlong Bio-Technique Profile
Table Shenzhen Neptunus Interlong Bio-Technique Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Shenzhen Neptunus Interlong Bio-Technique Recombinant Protein Drug Sales Volume and Growth Rate
Figure Shenzhen Neptunus Interlong Bio-Technique Revenue (Million USD) Market Share 2017-2022
Table Changchun High & New Technology Industry Profile
Table Changchun High & New Technology Industry Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Changchun High & New Technology Industry Recombinant Protein Drug Sales Volume and Growth Rate
Figure Changchun High & New Technology Industry Revenue (Million USD) Market Share 2017-2022
Table Sanofi Profile
Table Sanofi Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi Recombinant Protein Drug Sales Volume and Growth Rate
Figure Sanofi Revenue (Million USD) Market Share 2017-2022
Table Ortho Biotech Profile
Table Ortho Biotech Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Ortho Biotech Recombinant Protein Drug Sales Volume and Growth Rate
Figure Ortho Biotech Revenue (Million USD) Market Share 2017-2022
Table Abcam Profile
Table Abcam Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abcam Recombinant Protein Drug Sales Volume and Growth Rate
Figure Abcam Revenue (Million USD) Market Share 2017-2022
Table Eli Lilly Profile
Table Eli Lilly Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Eli Lilly Recombinant Protein Drug Sales Volume and Growth Rate
Figure Eli Lilly Revenue (Million USD) Market Share 2017-2022
Table NCPC Profile
Table NCPC Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure NCPC Recombinant Protein Drug Sales Volume and Growth Rate
Figure NCPC Revenue (Million USD) Market Share 2017-2022
Table Kyowa Hakko Kirin Profile
Table Kyowa Hakko Kirin Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Kyowa Hakko Kirin Recombinant Protein Drug Sales Volume and Growth Rate
Figure Kyowa Hakko Kirin Revenue (Million USD) Market Share 2017-2022
Table Novo Nordisk Profile
Table Novo Nordisk Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novo Nordisk Recombinant Protein Drug Sales Volume and Growth Rate
Figure Novo Nordisk Revenue (Million USD) Market Share 2017-2022
Table SL PHARM Profile
Table SL PHARM Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure SL PHARM Recombinant Protein Drug Sales Volume and Growth Rate
Figure SL PHARM Revenue (Million USD) Market Share 2017-2022
Figure Recombinant Protein Drug Product Picture
Table Global Recombinant Protein Drug Market Sales Volume and CAGR (%) Comparison by Type
Table Recombinant Protein Drug Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Recombinant Protein Drug Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Recombinant Protein Drug Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Recombinant Protein Drug Industry Development
Table Global Recombinant Protein Drug Sales Volume by Player (2017-2022)
Table Global Recombinant Protein Drug Sales Volume Share by Player (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume Share by Player in 2021
Table Recombinant Protein Drug Revenue (Million USD) by Player (2017-2022)
Table Recombinant Protein Drug Revenue Market Share by Player (2017-2022)
Table Recombinant Protein Drug Price by Player (2017-2022)
Table Recombinant Protein Drug Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Recombinant Protein Drug Sales Volume, Region Wise (2017-2022)
Table Global Recombinant Protein Drug Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume Market Share, Region Wise in 2021
Table Global Recombinant Protein Drug Revenue (Million USD), Region Wise (2017-2022)
Table Global Recombinant Protein Drug Revenue Market Share, Region Wise (2017-2022)
Figure Global Recombinant Protein Drug Revenue Market Share, Region Wise (2017-2022)
Figure Global Recombinant Protein Drug Revenue Market Share, Region Wise in 2021
Table Global Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Recombinant Protein Drug Sales Volume by Type (2017-2022)
Table Global Recombinant Protein Drug Sales Volume Market Share by Type (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume Market Share by Type in 2021
Table Global Recombinant Protein Drug Revenue (Million USD) by Type (2017-2022)
Table Global Recombinant Protein Drug Revenue Market Share by Type (2017-2022)
Figure Global Recombinant Protein Drug Revenue Market Share by Type in 2021
Table Recombinant Protein Drug Price by Type (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume and Growth Rate of Recombinant Insulin (2017-2022)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Insulin (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume and Growth Rate of Recombinant Human Interferon (rhIFN) (2017-2022)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Interferon (rhIFN) (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume and Growth Rate of Recombinant Human Erythropoietin (rhEPO) (2017-2022)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Erythropoietin (rhEPO) (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) (2017-2022)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume and Growth Rate of Recombinant Human Growth Hormone (rhGH) (2017-2022)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Growth Hormone (rhGH) (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rhFSH) (2017-2022)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rhFSH) (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Recombinant Protein Drug Consumption by Application (2017-2022)
Table Global Recombinant Protein Drug Consumption Market Share by Application (2017-2022)
Table Global Recombinant Protein Drug Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Recombinant Protein Drug Consumption Revenue Market Share by Application (2017-2022)
Table Global Recombinant Protein Drug Consumption and Growth Rate of Hospital use (2017-2022)
Table Global Recombinant Protein Drug Consumption and Growth Rate of Clinic use (2017-2022)
Table Global Recombinant Protein Drug Consumption and Growth Rate of Household (2017-2022)
Figure Global Recombinant Protein Drug Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Recombinant Protein Drug Price and Trend Forecast (2022-2027)
Figure USA Recombinant Protein Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Recombinant Protein Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Recombinant Protein Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Recombinant Protein Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Recombinant Protein Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Recombinant Protein Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Recombinant Protein Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Recombinant Protein Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Recombinant Protein Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Recombinant Protein Drug Market Sales Volume Forecast, by Type
Table Global Recombinant Protein Drug Sales Volume Market Share Forecast, by Type
Table Global Recombinant Protein Drug Market Revenue (Million USD) Forecast, by Type
Table Global Recombinant Protein Drug Revenue Market Share Forecast, by Type
Table Global Recombinant Protein Drug Price Forecast, by Type
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Insulin (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Insulin (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Interferon (rhIFN) (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Interferon (rhIFN) (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Erythropoietin (rhEPO) (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Erythropoietin (rhEPO) (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Growth Hormone (rhGH) (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Growth Hormone (rhGH) (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rhFSH) (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rhFSH) (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Recombinant Protein Drug Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Recombinant Protein Drug Market Consumption Forecast, by Application
Table Global Recombinant Protein Drug Consumption Market Share Forecast, by Application
Table Global Recombinant Protein Drug Market Revenue (Million USD) Forecast, by Application
Table Global Recombinant Protein Drug Revenue Market Share Forecast, by Application
Figure Global Recombinant Protein Drug Consumption Value (Million USD) and Growth Rate of Hospital use (2022-2027)
Figure Global Recombinant Protein Drug Consumption Value (Million USD) and Growth Rate of Clinic use (2022-2027)
Figure Global Recombinant Protein Drug Consumption Value (Million USD) and Growth Rate of Household (2022-2027)
Figure Recombinant Protein Drug Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Pharmingen Profile
Table Pharmingen Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pharmingen Recombinant Protein Drug Sales Volume and Growth Rate
Figure Pharmingen Revenue (Million USD) Market Share 2017-2022
Table Anhui Anke Biotechnology Profile
Table Anhui Anke Biotechnology Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Anhui Anke Biotechnology Recombinant Protein Drug Sales Volume and Growth Rate
Figure Anhui Anke Biotechnology Revenue (Million USD) Market Share 2017-2022
Table Livzon Pharmaceutical Profile
Table Livzon Pharmaceutical Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Livzon Pharmaceutical Recombinant Protein Drug Sales Volume and Growth Rate
Figure Livzon Pharmaceutical Revenue (Million USD) Market Share 2017-2022
Table Heng Rui Profile
Table Heng Rui Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Heng Rui Recombinant Protein Drug Sales Volume and Growth Rate
Figure Heng Rui Revenue (Million USD) Market Share 2017-2022
Table GenSci Profile
Table GenSci Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GenSci Recombinant Protein Drug Sales Volume and Growth Rate
Figure GenSci Revenue (Million USD) Market Share 2017-2022
Table Roche Profile
Table Roche Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Roche Recombinant Protein Drug Sales Volume and Growth Rate
Figure Roche Revenue (Million USD) Market Share 2017-2022
Table Amgen Profile
Table Amgen Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Recombinant Protein Drug Sales Volume and Growth Rate
Figure Amgen Revenue (Million USD) Market Share 2017-2022
Table Merck Serono Profile
Table Merck Serono Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck Serono Recombinant Protein Drug Sales Volume and Growth Rate
Figure Merck Serono Revenue (Million USD) Market Share 2017-2022
Table Shenzhen Neptunus Interlong Bio-Technique Profile
Table Shenzhen Neptunus Interlong Bio-Technique Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Shenzhen Neptunus Interlong Bio-Technique Recombinant Protein Drug Sales Volume and Growth Rate
Figure Shenzhen Neptunus Interlong Bio-Technique Revenue (Million USD) Market Share 2017-2022
Table Changchun High & New Technology Industry Profile
Table Changchun High & New Technology Industry Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Changchun High & New Technology Industry Recombinant Protein Drug Sales Volume and Growth Rate
Figure Changchun High & New Technology Industry Revenue (Million USD) Market Share 2017-2022
Table Sanofi Profile
Table Sanofi Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi Recombinant Protein Drug Sales Volume and Growth Rate
Figure Sanofi Revenue (Million USD) Market Share 2017-2022
Table Ortho Biotech Profile
Table Ortho Biotech Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Ortho Biotech Recombinant Protein Drug Sales Volume and Growth Rate
Figure Ortho Biotech Revenue (Million USD) Market Share 2017-2022
Table Abcam Profile
Table Abcam Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abcam Recombinant Protein Drug Sales Volume and Growth Rate
Figure Abcam Revenue (Million USD) Market Share 2017-2022
Table Eli Lilly Profile
Table Eli Lilly Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Eli Lilly Recombinant Protein Drug Sales Volume and Growth Rate
Figure Eli Lilly Revenue (Million USD) Market Share 2017-2022
Table NCPC Profile
Table NCPC Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure NCPC Recombinant Protein Drug Sales Volume and Growth Rate
Figure NCPC Revenue (Million USD) Market Share 2017-2022
Table Kyowa Hakko Kirin Profile
Table Kyowa Hakko Kirin Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Kyowa Hakko Kirin Recombinant Protein Drug Sales Volume and Growth Rate
Figure Kyowa Hakko Kirin Revenue (Million USD) Market Share 2017-2022
Table Novo Nordisk Profile
Table Novo Nordisk Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novo Nordisk Recombinant Protein Drug Sales Volume and Growth Rate
Figure Novo Nordisk Revenue (Million USD) Market Share 2017-2022
Table SL PHARM Profile
Table SL PHARM Recombinant Protein Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure SL PHARM Recombinant Protein Drug Sales Volume and Growth Rate
Figure SL PHARM Revenue (Million USD) Market Share 2017-2022
